Featured in Vascular Disease Management (VDM): ICHOR & Naglreiter Elevator Incubator Innovating MedTech

Summary: NAGLREITER MedTech Incubator ( accelerates time to market with state of the art facilities, business systems, and a proven track record with industry exits and partnerships in partnerships in Neurovascular, Robotics, Cardiovascular, Digital Health, End Effectors, Blades, Scopes, etc. “We develop devices that will win in the marketplace through insights, coordinated and efficient systems,…

Read More

ICHOR Case Study with NAMSA

Virtual Vascular Device Company Partners with NAMSA to Accelerate 510(k) Clearance by 30 Percent Research Challenge Peripheral Arterial Disease (PAD) is a condition that produces arterial fatty deposits and narrowed blood vessels, resulting in restricted blood flow to the arms, kidneys, stomach and most commonly, the legs. Worldwide, 14+ million people suffer from PAD with…

Read More

ICHOR Vascular Featured in Endovascular Today

ICHOR Vascular was recently featured in Endovascular Today. The article, “ICHOR Vascular’s Reperfusion System Cleared by FDA,” discusses how the newly-approved Ichor system targets vascular occlusions by eliminating the need for surgery or drug therapies. Highlights: ICHOR Vascular received FDA 510(k) clearance for the sale of its Ichor Panacea percutaneous reperfusion system, which is designed…

Read More
ICHOR Percutaneous Reperfusion System

ICHOR Vascular announces FDA clearance of the ICHOR Reperfusion System 

Miami, FL – ICHOR Vascular (, a company focused on the treatment of vascular occlusions, recently received 510(k) clearance for sale of its ICHOR Percutaneous Reperfusion System. ICHOR is a Percutaneous Reperfusion System designed to treat organized thrombus and embolic events in the peripheral vasculature. ICHOR is a “one size fits all” system that replicates…

Read More